^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Vx-001

    i
    Other names: Vx-001, Vx001
    Associations

    News

    Trials
    Company:
    Vaxon Biotech
    Drug class:
    Tumor-associated antigen inhibitor
    Related drugs:
    Associations

    News

    Trials
    3years
    Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC. (PubMed, Cancers (Basel))
    These results support the hypothesis that Vx-001 may be efficient in patients with non-immunogenic/cold but not with immunogenic/hot tumors.
    Clinical • Journal • Tumor Mutational Burden • PD(L)-1 Biomarker • IO biomarker
    |
    TMB (Tumor Mutational Burden) • CD8 (cluster of differentiation 8) • GZMB (Granzyme B)
    |
    PD-L1 expression
    |
    Vx-001